心血管生物标记物



心血管biomarker
心血管的生物标记是心血管疾病诊断、治疗和监控的关键。近年来，科研人员在寻找心血管的生物标记物，使用生物标记物方面取得一些可喜进展。为此CMBI搜集了最近关于心血管biomarker的综述文献供大家参考。更多文献，请用相关关键词通过CMBI文献查询获取。
Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product Nε-carboxymethyl-lysine in healthy Swedish men No-reflow phenomenon and prognosis in patients with acute myocardial infarction Serum peptidome for cancer detection C-reactive protein and cardiovascular disease Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes predicting coronary heart disease in asymptomatic individuals N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease Interleukin-6 –174G-C Polymorphism and Ischemic Stroke Comparison of Midregional Pro-Atrial Natriuretic Peptide With N-Terminal Pro-B-Type Natriuretic Peptide in Predicting Survival in Patients With Chronic Heart Failure Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality After Acute Coronary Syndrome and Identifies High-Risk Patients Across the Range of Troponin Values Contemporary Scientific Insights-Role of Biomarkers of Inflammation in Cardiovascular Disease-Atherosclerosis Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure Association between anaemia and N-terminal pro-B-type natriuretic peptide (NT-proBNP) Elevated Serum S100B Levels Indicate a Higher Risk of Hemorrhagic Transformation After Thrombolytic Therapy in Acute Stroke. Independent effects of both right and left ventricular function on plasma brain natriuretic peptide The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T Adiposity of the Heart Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke Autoantibody microarrays for biomarker discovery- Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases Biomarker screening for cardiac dysfunction Biomarkers for oxidative stress B-type natriuretic peptide monitoring in the Pediatric ICU population Can biomarkers improve prediction of future cardiovascular events in patients with cardiovascular disease Cardiac Enzymes, Renal Failure and Renal Transplantation Circulating microparticles-pathophysiology and clinical implications- CRP has little incremental value over traditional cardiovascular risk factors in risk stratification CRP has little incremental value over traditional cardiovascular risk factors in risk stratification Endothelial function and dysfunction-testing and clinical relevance From Vulnerable Plaque to Vulnerable Patient-The Search for Biomarkers of Plaque Destabilization heart failure-Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure High-performance liquid chromatography (HPLC) determination of inosine, a potential biomarker for initial cardiac ischaemia, using isolated mouse hearts Lp-PLA2-A New Kid on the Block personalized medicine-The use of transcriptomic biomarkers for personalized medicine Predictors of Mortality in Chronic Chagas Disease Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease Redefining risk in acute coronary syndromes using molecular medicine Role of Biomarkers of Inflammation in Cardiovascular Disease- Role of Biomarkers of Inflammation in Cardiovascular Disease-Atherosclerosis.- Role of C-reactive protein in coronary risk reduction Biomarkers in the Prevention and Treatment of Atherosclerosis-Need, Validation, and Future Biomarkers of Atherosclerotic Plaque Instability and Rupture- Prognostic Value and Echocardiographic Determinants of Plasma Myeloperoxidase Levels in Chronic Heart Failure The Effect of Weight Loss on C-Reactive Protein The potential to improve primary prevention in the future by using BNP-N-BNP as an indicator of silent ‘pancardiac’ target organ damage The Value of Bedside Cardiac Multibiomarker Assay in Rapid and Accurate Diagnosis of Acute Coronary Syndromes Unbound Free Fatty Acids and Heart-Type Fatty Acid–Binding Protein-Diagnostic Assays and Clinical Applications The microenvironment can shift erythrocytes from a friendly to a harmful behavior Circulating Secretory Phospholipase A2 Activity and Risk of Incident Coronary Events in Healthy Men and Women-The EPIC-NORFOLK Study. Alternate Circulating Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide Forms in the General Population Short-Term Serial Sampling of Natriuretic Peptides in Patients Presenting With Chest Pain Acute Coronary Syndromes Biochemical Markers in Acute Coronary Syndromes and Heart Failure Coronary Artery Calcium-Should We Rely on This Surrogate Marker Differential Expression of Chemokines, Risk of Stable Coronary Heart Disease, and Correlation with Established Cardiovascular Risk Markers Indications for Novel Markers of Coronary Collateralization Role of C-Reactive Protein in Coronary Risk Reduction The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction Circulating (cell-free) nucleic acids Elevated levels of platelet–monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome A biomarker for risk assessment in patients with acute coronary syndromes Can biomarkers improve prediction of future cardiovascular events in patients with cardiovascular disease Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk The Framingham Heart Study of Atherosclerotic Plaque Instability and Rupture Can cardiac MRI predict outcome in patients at risk for unrecognized myocardial infarction Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death Circulating endothelial cells-A novel marker of endothelial damage Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk anp-Natriuretic peptides in the diagnosis and management of heart failure Biomarker of Myocardial Fibrosis Predicts Long-Term Response to Cardiac Resynchronization Therapy Biomarkers and Clinical Proteomics Cardiac Marker Results Without Loss of Diagnostic Accuracy C-type natriuretic peptide and heart failure Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients Genetic Diagnosis and Testing in Clinical Practice renal-BIOMARKERS OF ACUTE RENAL INJURY AND RENAL FAILURE Adiponectin With Coronary Vascular Lesions anp-Relation of Left Atrial Volume to B-Type Natriuretic Peptide Levels in Patients With Stable Chronic Heart Failure Association of TNF serum levels and TNFA promoter polymorphisms with risk of myocardial infarction Biomaterials for the Treatment of Myocardial Infarction Coronary Artery Disease Prognosis and C-Reactive Protein Levels Improve in Proportion to Percent Lowering of Low-Density Lipoprotein C-reactive protein levels and coronary artery disease incidence and mortality Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome Genomic medicine-bringing biomarkers to clinical medicine Interleukin-6 and the Risk of Future Cardiovascular Events in Patients With Angina Pectoris and Myocardial Infarction Leptin as a new diagnostic tool in chronic heart failure Patent foramen ovale is a marker of carcinoid heart disease progression Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes proteome-Biology of atherosclerotic plaques-What we are learning from proteomic analysis proteome-The clinical application of proteomics reactive protein in cardiovascular disease-Risk marker or pathogen Biomarkers of drug-induced vascular injury Serum uric acid and risk of ischemic stroke Significance of Vascular Nitric Oxide Synthase Pathways in Coronary Artery Disease stroke-Association of Serial Biochemical Markers With Acute Ischemic Stroke Troponin-T and N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality Benefit From Coronary Revascularization in Acute Coronary Syndromes The exciting story of cardiac biomarkers Circulating markers of endothelial function in cardiovascular disease C-reactive protein comes of age C-reactive protein is a poor predictor of subclinical atherosclerosis C-reactive protein levels are increased in active carotid artery plaques Do mechanical markers of myocardial ischaemia predict of myocardial infarction lipid-Serum markers of vascular inflammation in dyslipemia Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke Modifications of Coronary Risk Factors Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure Biomarkers in Acute Cardiac Disease The exciting story of cardiac biomarkers The prognostic value of N-terminal proB-type natriuretic peptide Tumour markers in chronic heart failure Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure Circulating Microparticles C-reactive protein in atherosclerosis Decrease in plasma B-type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients heart failure-Myocardial regulatory proteins and heart failure Relationship between cytokines and tumour markers in patients with chronic heart failure Biomarkers in Acute Cardiac Disease Serum biomarkers for heart failure Vascular Biomarkers and Surrogates in Cardiovascular Disease Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state Application of intravascular ultrasound in anti-atherosclerotic drug development Apolipoproteins as markers and managers of coronary risk association between elevated levels of inflammation biomarkers and coronary artery disease Association of Soluble Markers with Various Stages and Major Events of Atherosclerosis Cardiac biomarkers-a contemporary status report C-reactive protein's place on the cardiovascular stage Detection of specific nitrotyrosine-modified proteins as a marker of oxidative stress in cardiovascular disease Inflammatory Biomarkers in Acute Coronary Syndromes-1 Inflammatory Biomarkers in Acute Coronary Syndromes-1 Introduction and Cytokines Inflammatory Biomarkers in Acute Coronary Syndromes-2 Inflammatory Biomarkers in Acute Coronary Syndromes-2 Inflammatory Biomarkers in Acute Coronary Syndromes-4 Iterleukin 1 alpha is a marker of endothelial cellular senescent Leptin as a new diagnostic tool in chronic heart failure Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke Midregional Pro-A-Type Natriuretic Peptide Measurements for Diagnosis of Acute Destabilized Heart Failure Novel cardiovascular biomarkers and implications for clinical trials novel role of C-reactive protein in cardiovascular disease Physicians' Decisions to Withhold and Withdraw Life-Sustaining Treatment Biomarkers for coronary artery disease Biomarkers of oxidative damage in human disease Biomarkers of Cardiovascular Disease Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome Novel Protein Markers of Acute Coronary Syndrome Complications in Low-Risk Outpatients of Cardiovascular Disease Serum biomarkers for heart failure The Accuracy of Surrogate Decision Makers The Antibody Configurations of Cardiac Troponin I Assays May Determine Their Clinical Performance Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction PHARMACOL-pharmacogenomics-Biomarkers Cardiac isoform of alpha-2 macroglobulin—A new biomarker for myocardial infarcted diabetic patients Improved Identification of Patients With Coronary Artery Disease by the Use of New Lipid and Lipoprotein Biomarkers Inflammatory Biomarkers in Acute Coronary Syndromes-1 Introduction and Cytokines Biomarkers for coronary artery disease Cardiac biomarkers a contemporary status report The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis The use of fatty acid biomarkers to reflect dietary intake biomarkeers-Polyamine Oxidase and Acrolein as Novel Biochemical Markers for Diagnosis of Cerebral Stroke Drinking Frequency, Mediating Biomarkers, and Risk of Myocardial Infarction in Women and Men biomarkers for coronary heart disease-predictive value or background noise 5-lipoxygenase-activating protein inhibitor on biomarkers of myocardial infarction a new marker of coronary calcification a simplified approach to the management of non-st-segment elevation acute coronary syndromes ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia acute coronary syndrome biomarkers acute coronary syndromes acute ischemic cerebrovascular syndrome-diagnostic criteria an evidence-based approach to prognostic markers Aortic Dissection-New Frontiers in Diagnosis and aortic dissection-new frontiers in diagnosis and management-part ii are circulating cd133+ cells biomarkers of vascular disease assessment and management of patients with ischemic heart disease Assessment of reaching goal in patients with combined hyperlipidemia-LDL, non-HDLo atherosclerotic disease regression with statins-studies using vascular markers atherosclerotic plaque rupture-local or systemic process atherothrombosis and high-risk plaque b type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure Bioluminescence technology for imaging cell proliferation biomarkers in the development of cox-2 inhibitors biomarkers of congenital obstructive nephropathy biomarkers of ischemia in patients with known coronary artery disease biomarkers of vascular disease linking inflammation to endothelial activation b-type natriuretic peptide B-Type Natriuretic Peptide as a Biomarker Beyond Heart Failure-Speculations and Opportunities b-type natriuretic peptide as a biomarker beyond heart failure-speculations and opportunities candidate-based proteomics in the search for biomarkers of cardiovascular disease cardiovascular mortality risk in chronic kidney disease chemokines in the pathogenesis of vascular disease circulating biomarkers in acute coronary syndromes circulating tissue kallikrein levels correlate with severity of carotid atherosclerosis combined measurements of cardiac troponin t and n-terminal pro-bnp in heart failure comparison between measures of atherosclerosis and risk of stroke contemporary management of acute coronary syndrome c-reactive protein and ldl cholesterol in atherosclerosis c-reactive protein comes of age c-reactive protein-using inflammation markers in cardiology crp-marker or maker of cardiovascular disease diabetes-molecular therapeutic target for type-2 diabetes differential expression of cardiac biomarkers by gender in patients with unstable angina-non-st-elevation myocardial infarction discovery in biological fluids discovery of protein biomarkers for renal diseases disseminated intravascular coagulation dna methylation, smooth muscle cells, and atherogenesis early brain natriuretic peptide increase reflects acute myocardial ischemia in patients with ongoing chest pain effects of cigarette reduction on cardiovascular risk factors and subjective measures effects of statin therapy on vascular dysfunction emerging, noninvasive surrogate markers of atherosclerosis endothelial function testing as a biomarker of vascular disease enhancing the development and approval of acute stroke established and emerging plasma biomarkers in the prediction of first atherothrombotic events evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging for mortality and cardiovascular events-in reply future of biomarkers in acute coronary syndromes genetic inflammatory factors predict restenosis after percutaneous coronary interventions genetic markers-progress and potential for cardiovascular disease genome scan of systemic biomarkers of vascular inflammation in the framingham heart study glycoprotein iib-iiia antagonists in non-st elevation acute coronary syndromes and percutaneous interventions high intraindividual variation of b-type natriuretic peptide (bnp) and amino-terminal probnp in patients with stable chronic heart failure how industry is approaching the search for new diagnostic markers and biomarkers implications of the new definition of myocardial infarction individualizing therapy in acute coronary syndromes-using a multiple biomarker inflammation and carotid artery-risk for atherosclerosis study interleukin-1 receptor family member st2 predict mortality and clinical outcome in acute myocardial infarction isoprostanes, emerging biomarkers and potential mediators in cardiovascular diseases laminopathies and atherosclerosis lipoprotein-associated phospholipase a2 as a biomarker for coronary disease and stroke magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris measurement of arterial wall thickness as a surrogate marker for atherosclerosis molecular imaging of antiangiogenic agents molecular imaging of the cardiovascular system mri of the myocardium myeloperoxidase and cardiovascular disease new risk factors for atherosclerosis in hypertension-focus on the prothrombotic state and lipoprotein(a new tools for coronary risk assessment non-hdl cholesterol, apolipoproteins a-i and b^sub 100^, standard lipid measures, lipid ratios, and crp non-interventional cardiac diagnostics noninvasive atherosclerosis imaging for predicting cardiovascular events and assessing therapeutic interventions non-invasive coronary angiography with multi-detector computed tomography noninvasive imaging of coronary arteries novel diagnostic test for acute stroke n-terminal pro-bnp, crp, and urinary albumin levels as predictors of mortality and cardiovascular events n-terminal pro-b-type natriuretic peptide and long-term mortality in stable coronary heart disease nt-probnp and bnp-biomarkers for heart failure management oxidative stress and cardiovascular injury oxidative stress and cardiovascular injury-part i periodontal disease and biomarkers related to cardiovascular disease peroxisome proliferator-activated receptors and atherogenesis plasma natriuretic peptide levels and the risk of cardiovascular events and death plasma nt-bnp as a marker of cardiac pump dysfunction plasma n-terminal pro-brain natriuretic peptide concentration predicts coronary events in men plasma surfactant protein-b-a novel biomarker in chronic heart failure possible applications of multislice computed tomography in clinical cardiology ppar[gamma]2 p12a polymorphism and risk of coronary heart disease prediction of myocardial infarction by n-terminal-pro-bnp, crp, and renin in cerebrovascular disease pro-bnp predicts significant coronary artery lesion in the unstable angina patients with normal pro-brain natriuretic peptide and c-reactive protein for risk stratification in stable and unstable coronary artery disease prognostic impact of plasma n-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure prognostic value of n-terminal prob-type natriuretic peptide protease-activated receptor signaling in the regulation of inflammation protein c-activated protein c pathway proteomics of heart disease pulmonary arterial hypertension-future directions report quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans quest for novel cardiovascular biomarkers by proteomic analysis recommendations for advancing development of acute stroke therapies regularized roc method for disease classification and biomarker selection with microarray data relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound researchers explore tools to identify individuals at risk for heart disease risk assessment in patients with unstable angina-non-st-elevation myocardial infarction risk factors for subarachnoid hemorrhage risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke role of lipoprotein-associated phospholipase a2 in atherosclerosis rosuvastatin in the primary prevention of cardiovascul disease high-sensitivity c-reactive protein selection of biomarkers by a multivariate statistical processing using multiple factor analysis serine proteases and cardiac function soluble adhesion molecules and the search for biomarkers for atherosclerosis stabilization of the patient with acute coronary syndromes statins and oxidative stress during strategies for developing biomarkers of heart failure structural and genetic bases of arterial stiffness surrogate markers for atherosclerotic disease the future of treatment for st-elevation myocardial infarction the prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease the role of protein kinase c in cerebral ischemic and reperfusion injury the vulnerable carotid artery plaque-current imaging methods and new perspectives tracking atherosclerosis regression-a clinical tool in preventive cardiology translating the human genome project into prevention of myocardial infarction and stroke-getting close Troponin-the biomarker of choice for the detection of cardiac injury use of biomarkers in the management of heart failure

Last Modified: 2008-02-18